Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mallinckrodt Plc (NYSE:MNK)

23.70
Delayed Data
As of 4:02pm ET
 +0.34 / +1.46%
Today’s Change
19.00
Today|||52-Week Range
55.32
-52.43%
Year-to-Date

Today’s Trading

Previous close23.36
Today’s open23.60
Day’s range23.26 - 23.92
Volume3,184,429
Average volume (3 months)3,120,373
Market cap$2.2B
Data as of 4:02pm ET, 12/18/2017

Growth & Valuation

Earnings growth (last year)+78.72%
Earnings growth (this year)--
Earnings growth (next 5 years)-3.00%
Revenue growth (last year)+1.01%
P/E ratio13.0
Price/Sales2.30
Price/Book0.47

Competitors

 Today’s
change
Today’s
% change
AKRXAkorn Inc-0.05-0.14%
AGNPRAAllergan plc+3.72+0.61%
TAROTaro Pharmaceutical ...-0.49-0.46%
CLVSClovis Oncology Inc+0.35+0.55%
Data as of 4:02pm ET, 12/18/2017

Financials

Next reporting dateFebruary 6, 2018
EPS forecast (this quarter)$1.69
Annual revenue (last year)$3.4B
Annual profit (last year)$548.0M
Net profit margin14.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Staines-Upon-Thames, Surrey

Forecasts